“Axillary Hyperhidrosis HDSM-Ax-7 Patient-Reported Outcomes for Sofpironium Topical Gel,12.45%: A Multicenter, Randomized, Controlled Double-Blind Study (NCT03836287)”, J of Skin, vol. 9, no. 4, p. s588, Jul. 2025, doi: 10.25251/yvdyat28.